# REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs

> **NCT05622721** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 200 (estimated)

## Conditions studied

- Dysbiosis
- Clostridium Difficile
- Pet-Human Bonding
- Antibiotic-Associated Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05622721
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-30
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05622721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05622721, "REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05622721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*